ADA’s Scientific Sessions: Day 3
Here are Drs. Jennifer Sun, Dana Lewis, and Christine Wang to share their key takeaways from day 3, with their commentary in the video and below.
ADA’s Scientific Sessions: Day 2
Drs. Danny Chou, Peter Arvan, Jeffrey Millman, and Efsun Arda will share their key takeaways from day 2, with their commentary in the video and below.
ADA’s Scientific Sessions: Day 1
Here are Drs. Candace Reno and Luiza Caramori share their key takeaways from day 1, with their commentary in the video and below.
Artificial Intelligence Identifies T1D Risk Factors in Children
Breakthrough T1D and IBM Research have published their first paper, applying world-class computing power to identify factors leading to the onset of T1D in children.
Diabetes-Friendly Summer Recipes for Family and Friends
We asked. You delivered. Nine summertime, diabetes-friendly recipes from members of the Breakthrough T1D community. Bonus: most require no cooking!
Breakthrough T1D Heads, Virtually, to ADA’s 81st Scientific Sessions
At the ADA's 81st Scientific Sessions, healthcare professionals will gather at one of the largest conferences of diabetes researchers in the world.
T1D Doesn’t Discriminate: Know Your Risk with T1Detect
How Breakthrough T1D’s screening education and awareness program can help address health disparities experienced by underserved members of the T1D community.
Just in Time for Father’s Day: Husband, Dad of T1D Family Shares His Experiences
Peterson Cilaire, husband and father of a T1D family, on loving someone who lives with T1D, learning to manage T1D and the importance of fathers and husbands.
How Coming Out Helped Me Accept My T1D Diagnosis
In recognition of Pride Month, Breakthrough T1D shares the first-hand account of a member of the LGBTQ+ community who explains how coming out helped him accept his T1D diagnosis.
FDA Advisory Committee Recommends that Teplizumab Receives Approval
An FDA Advisory Committee weighed the evidence, and the results were positive: They recommended that the FDA approve teplizumab for at-risk individuals.